| 000 | 05019nam a22006135i 4500 | ||
|---|---|---|---|
| 001 | 978-1-0716-3307-6 | ||
| 003 | DE-He213 | ||
| 005 | 20260610083638.0 | ||
| 007 | cr nn 008mamaa | ||
| 008 | 230718s2023 xxu| s |||| 0|eng d | ||
| 020 |
_a9781071633076 _9978-1-0716-3307-6 |
||
| 024 | 7 |
_a10.1007/978-1-0716-3307-6 _2doi |
|
| 050 | 4 | _aRC346-429.2 | |
| 072 | 7 |
_aPSAN _2bicssc |
|
| 072 | 7 |
_aSCI089000 _2bisacsh |
|
| 072 | 7 |
_aPSAN _2thema |
|
| 082 | 0 | 4 |
_a616.8 _223 |
| 245 | 1 | 0 |
_aSchizophrenia _h[electronic resource] : _bMethods and Protocols / _cedited by Leyre Urigüen, Rebeca Díez-Alarcia. |
| 250 | _a1st ed. 2023. | ||
| 264 | 1 |
_aNew York, NY : _bSpringer US : _bImprint: Humana, _c2023. |
|
| 300 |
_aX, 155 p. 25 illus., 19 illus. in color. _bonline resource. |
||
| 336 |
_atext _btxt _2rdacontent |
||
| 337 |
_acomputer _bc _2rdamedia |
||
| 338 |
_aonline resource _bcr _2rdacarrier |
||
| 341 | 0 |
_bTable of contents navigation _2onix |
|
| 341 | 0 |
_bSingle logical reading order _2onix |
|
| 341 | 0 |
_bShort alternative textual descriptions _2onix |
|
| 341 | 0 |
_bUse of color is not sole means of conveying information _2onix |
|
| 341 | 0 |
_bUse of high contrast between text and background color _2onix |
|
| 341 | 0 |
_bNext / Previous structural navigation _2onix |
|
| 341 | 0 |
_bAll non-decorative content supports reading without sight _2onix |
|
| 347 |
_atext file _bPDF _2rda |
||
| 490 | 1 |
_aMethods in Molecular Biology, _x1940-6029 ; _v2687 |
|
| 505 | 0 | _aA Novel Method to Estimate Levels of Receptors Using an Allosteric Modulator. Focus on muscarinic M1 receptors -- Enhanced bystander BRET (ebBRET) biosensors as biophysical tools to map the signaling profile of neuropsychiatric drugs targeting GPCR -- [35S]GTPγS (Guanosine-5′-O-(γ-thio)triphosphate-[35S]) Binding Scintillation Proximity Assay experiments in postmortem brain tissue -- CRISPR/Cas9 as a simple technique for the generation of murine knockout models for neuropsychiatric diseasesEvaluation of sensory-motor gating deficits in mice th -- rough prepulse inhibition (PPI) of the startle response -- Automated detection of psychedelic-induced head twitch response in mice -- Gastrointestinal and microbiome profiling in rodent models of neurological and psychiatric disorders -- Electroencephalography for the study of the auditory P300 evoked potential and derived measurements -- Quantification of endocannabinoids in human plasma -- Neuropsychological and functional assessment of cognitive impairments in schizophrenia -- Clinical management and assessment of the early stages of psychosis: a multidimensional approach. | |
| 520 | _aThis volumes presents current methods used in the research of schizophrenia. Chapters guide readers through molecular techniques, in vivo approaches, cell cultures and heterologous expression systems, and even research methods involving human studies. Written in the highly successful Methods in Molecular Biology series format, chapters include introductions to their respective topics, lists of the necessary materials and reagents, step-by-step, readily reproducible laboratory protocols, and key tips on troubleshooting and avoiding known pitfalls. Authoritative and cutting-edge, Schizophrenia: Methods and Protocols aims to be a useful and practical guide to new researchers and experts looking to expand their knowledge. | ||
| 532 | 8 | _aAccessibility summary: This PDF does not fully comply with PDF/UA standards, but does feature limited screen reader support, described non-text content (images, graphs), bookmarks for easy navigation and searchable, selectable text. Users of assistive technologies may experience difficulty navigating or interpreting content in this document. We recognize the importance of accessibility, and we welcome queries about accessibility for any of our products. If you have a question or an access need, please get in touch with us at accessibilitysupport@springernature.com. | |
| 532 | 8 | _aNo reading system accessibility options actively disabled | |
| 532 | 8 | _aPublisher contact for further accessibility information: accessibilitysupport@springernature.com | |
| 650 | 0 |
_aNervous system _xDiseases. |
|
| 650 | 0 | _aNeuropharmacology. | |
| 650 | 1 | 4 | _aNeurological Disorders. |
| 650 | 2 | 4 | _aNeuropharmacology. |
| 700 | 1 |
_aUrigüen, Leyre. _eeditor. _0(orcid)0000-0002-1296-6895 _1https://orcid.org/0000-0002-1296-6895 _4edt _4http://id.loc.gov/vocabulary/relators/edt |
|
| 700 | 1 |
_aDíez-Alarcia, Rebeca. _eeditor. _0(orcid)0000-0002-0806-9825 _1https://orcid.org/0000-0002-0806-9825 _4edt _4http://id.loc.gov/vocabulary/relators/edt |
|
| 710 | 2 | _aSpringerLink (Online service) | |
| 773 | 0 | _tSpringer Nature eBook | |
| 776 | 0 | 8 |
_iPrinted edition: _z9781071633069 |
| 776 | 0 | 8 |
_iPrinted edition: _z9781071633083 |
| 776 | 0 | 8 |
_iPrinted edition: _z9781071633090 |
| 830 | 0 |
_aMethods in Molecular Biology, _x1940-6029 ; _v2687 |
|
| 856 | 4 | 0 | _uhttps://doi.org/10.1007/978-1-0716-3307-6 |
| 912 | _aZDB-2-PRO | ||
| 999 |
_c5968 _d5968 |
||